Bioiberica’s Chondroitin Sulfate API is a high-quality, animal origin ingredient for the development of finished pharmaceutical formulations targeting osteoarthritis and joint discomfort. Our pharmaceutical grade chondroitin sulfate is manufactured in Europe under strict GMP quality standards and complies with US and EU Pharmacopoeias.
Chondroitin sulfate is a sulfated glycosaminoglycan found naturally in the extracellular matrix (ECM) of cartilage – a flexible connective tissue that keeps joint movement fluid and flexible. As individuals age, their cartilage wears down which can result in the onset of degenerative joint disorders, causing pain, stiffness, and loss of articular function. Pharmaceutical grade chondroitin sulfate is proven to improve articular symptoms of degeneration. Bioiberica is a leading manufacturer of animal-derived chondroitin sulfate API, which is available from bovine or porcine origins.
Chondroitin sulfate API is considered a Symptomatic Slow Acting Drug for osteoarthritis, helping to support joint health and improve mobility. For many individuals, it is a welcome treatment for joint pain.
Bioiberica is your trusted partner for innovation in the mobility market. In addition to our specialisation in animal origin chondroitin sulfate API, we offer the quality and technical support and regulatory expertise pharmaceutical manufacturers need to bring their products to market faster and with enduring success.
Download our product information sheet to learn more about Chondroitin Sulfate API and how Bioiberica can support the development of safe and effective mobility solutions for the pharma market.